Femasys Inc. operates as a biomedical company. The Company researches, develops, and manufactures novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. Femasys serves customers worldwide.

S-3/A | Registration statement for specified transactions by certain issuers (Amendment)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Femasys (FEMY US)

S-3/A | Registration statement for specified transactions by certain issuers (Amendment)

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Current Report (Form 8-K | Period ending 2025-11-10)

Current Report (Form 8-K | Period ending 2025-11-03)

Current Report (Form 8-K | Period ending 2025-11-03)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)